Asia Pacific Drug Delivery Devices Market: By Product Type, By Route of Administration, By Formulation, By Application, By Distribution Channel, and Country Forecast 2020-2031

download arrow download arrow Download Sample
settings arrow settings arrow email us

Asia Pacific Drug Delivery Devices Market: By Product Type (Infusion Pumps, Metered Dose Inhalers, Nebulizers, Syringes, Ocular Inserts, Nasal Sprays, Implantable Drug Delivery Devices, Transdermal Patches, Trans-Mucosal Drug Delivery Devices, Others), By Route of Administration (Oral, Parenteral, Transdermal, Trans-Mucosal, Inhalation, Ocular, Others), By Formulation (Solid, Liquid, Semi-Solid), By Application (Diabetes, Oncology, Autoimmune Disorders, Neurological Disorders, Gastrointestinal Disorders, Respiratory Disorders, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), and Country Forecast 2020-2031

checked icon checked icon arrow_drop_down
checked icon Single User License $3100 $2480
checked icon Multiple User License $4600 $3680
checked icon Corporate User License $6900 $5520

Asia Pacific Drug Delivery Devices Market size was valued at US$ X million in 2024 and is expected to reach US$ X million by 2031, growing at a significant CAGR of X% from 2025-2031. Drug delivery devices are used to deliver drugs or chemical substances into the body for therapeutic effects by using different formulations, technologies, and approaches. These devices can be used for diagnosis, treatment, cure, or prevention of various diseases such as diabetes, autoimmune disorders, bacterial and viral infections, and allergies among others. Various medicinal formulations such as antibiotics and insulin are most commonly administered by using these devices to increase the efficiency of the drug by controlling dosage, time, and releasing the drug at a specific site in the body.

Asia Pacific Drug Delivery Devices Market Dynamics

Drivers: Increase in the prevalence of chronic diseases such as diabetes and cancerin China, India, and Japan Adoption of newer drug delivery devices and acquisitions between the market players Rise in awareness about self-injector devices and development in healthcare expenditure

Restraints: Stringent regulation for the approval of drug delivery devices Product recalls and Complications in the use of drug delivery devices such as dosage errors High cost of drug delivery devices

Asia Pacific Drug Delivery Devices Market Segmentation Analysis

Report Benchmarks

Details

By Product Type

  • Infusion Pumps
  • Metered Dose Inhalers
  • Nebulizers
  • Syringes
  • Ocular Inserts
  • Nasal Sprays
  • Implantable Drug Delivery Devices
  • Transdermal Patches
  • Trans-Mucosal Drug Delivery Devices
  • Others

By Application

  • Diabetes
  • Oncology
  • Autoimmune Disorders
  • Neurological Disorders
  • Gastrointestinal Disorders
  • Respiratory Disorders
  • Others

By Formulation Type

  • Solid
  • Liquid
  • Semi-solid

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Key Features of the Report

  • The asia pacific drug delivery devices market report provides granular level information about the market size, regional market share, historic market (2020-2024), and forecast (2025-2031)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

Asia pacific drug delivery devices market size was valued at US$ X million in 2024 and is expected to reach US$ X million by 2031, growing at a significant CAGR of X%

The report covers the Asia Pacific drug delivery devices market data: China, India, Japan, Australia and New Zealand

The market key players are Becton Dickinson and Company, Hoffmann La Roche Ltd., Smiths medical Inc., Braun Melsungen AG, Pfizer, Inc. (U.S.)

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2. Asia Pacific Drug Delivery Devices Market Introduction 
2.1. Asia Pacific Drug Delivery Devices Market  - Taxonomy
2.2. Asia Pacific Drug Delivery Devices Market  - Definitions
2.2.1.Product Type
2.2.2.Application
2.2.3.Formulation Type
2.2.4.Distribution Channel
2.2.5.Country
3. Asia Pacific Drug Delivery Devices Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Asia Pacific Drug Delivery Devices Market Analysis, 2020 - 2024 and Forecast 2025 - 2031
4.1.  Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Asia Pacific Drug Delivery Devices Market  By Product Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
5.1. Infusion Pumps
5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Metered Dose Inhalers
5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Nebulizers
5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Syringes
5.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Ocular Inserts
5.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Nasal Sprays
5.6.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
5.7. Implantable Drug Delivery Devices
5.7.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.7.3. Market Opportunity Analysis 
5.8. Transdermal Patches
5.8.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.8.3. Market Opportunity Analysis 
5.9. Trans-Mucosal Drug Delivery Devices
5.9.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.9.3. Market Opportunity Analysis 
5.10. Others
5.10.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.10.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.10.3. Market Opportunity Analysis 
6. Asia Pacific Drug Delivery Devices Market  By Application, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
6.1. Diabetes
6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Oncology
6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Autoimmune Disorders
6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Neurological Disorders
6.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Gastrointestinal Disorders
6.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. Respiratory Disorders
6.6.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
6.7. Others
6.7.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.7.3. Market Opportunity Analysis 
7. Asia Pacific Drug Delivery Devices Market  By Formulation Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
7.1. Solid
7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Liquid
7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Semi-solid
7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8. Asia Pacific Drug Delivery Devices Market  By Distribution Channel, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
8.1. Hospital Pharmacies
8.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Retail Pharmacies
8.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Online Pharmacies
8.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Others
8.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
9. Asia Pacific Drug Delivery Devices Market  By Country, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
9.1. Asia Pacific (APAC)
9.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. China
9.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. India
9.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Australia and New Zealand (ANZ)
9.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Japan
9.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
9.6. Rest of APAC
9.6.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
9.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.6.3. Market Opportunity Analysis 
10.Asia Pacific (APAC) Asia Pacific Drug Delivery Devices Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
10.1. Product Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Infusion Pumps
10.1.2.Metered Dose Inhalers
10.1.3.Nebulizers
10.1.4.Syringes
10.1.5.Ocular Inserts
10.1.6.Nasal Sprays
10.1.7.Implantable Drug Delivery Devices
10.1.8.Transdermal Patches
10.1.9.Trans-Mucosal Drug Delivery Devices
10.1.10.Others
10.2.  Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Diabetes
10.2.2.Oncology
10.2.3.Autoimmune Disorders
10.2.4.Neurological Disorders
10.2.5.Gastrointestinal Disorders
10.2.6.Respiratory Disorders
10.2.7.Others
10.3.  Formulation Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Solid
10.3.2.Liquid
10.3.3.Semi-solid
10.4.  Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Hospital Pharmacies
10.4.2.Retail Pharmacies
10.4.3.Online Pharmacies
10.4.4.Others
11.China Asia Pacific Drug Delivery Devices Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
11.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Infusion Pumps
11.1.2.Metered Dose Inhalers
11.1.3.Nebulizers
11.1.4.Syringes
11.1.5.Ocular Inserts
11.1.6.Nasal Sprays
11.1.7.Implantable Drug Delivery Devices
11.1.8.Transdermal Patches
11.1.9.Trans-Mucosal Drug Delivery Devices
11.1.10.Others
11.2.  Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Diabetes
11.2.2.Oncology
11.2.3.Autoimmune Disorders
11.2.4.Neurological Disorders
11.2.5.Gastrointestinal Disorders
11.2.6.Respiratory Disorders
11.2.7.Others
11.3.  Formulation Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Solid
11.3.2.Liquid
11.3.3.Semi-solid
11.4.  Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Hospital Pharmacies
11.4.2.Retail Pharmacies
11.4.3.Online Pharmacies
11.4.4.Others
12.India Asia Pacific Drug Delivery Devices Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
12.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Infusion Pumps
12.1.2.Metered Dose Inhalers
12.1.3.Nebulizers
12.1.4.Syringes
12.1.5.Ocular Inserts
12.1.6.Nasal Sprays
12.1.7.Implantable Drug Delivery Devices
12.1.8.Transdermal Patches
12.1.9.Trans-Mucosal Drug Delivery Devices
12.1.10.Others
12.2.  Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Diabetes
12.2.2.Oncology
12.2.3.Autoimmune Disorders
12.2.4.Neurological Disorders
12.2.5.Gastrointestinal Disorders
12.2.6.Respiratory Disorders
12.2.7.Others
12.3.  Formulation Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Solid
12.3.2.Liquid
12.3.3.Semi-solid
12.4.  Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Hospital Pharmacies
12.4.2.Retail Pharmacies
12.4.3.Online Pharmacies
12.4.4.Others
13.Australia and New Zealand (ANZ) Asia Pacific Drug Delivery Devices Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
13.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Infusion Pumps
13.1.2.Metered Dose Inhalers
13.1.3.Nebulizers
13.1.4.Syringes
13.1.5.Ocular Inserts
13.1.6.Nasal Sprays
13.1.7.Implantable Drug Delivery Devices
13.1.8.Transdermal Patches
13.1.9.Trans-Mucosal Drug Delivery Devices
13.1.10.Others
13.2.  Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Diabetes
13.2.2.Oncology
13.2.3.Autoimmune Disorders
13.2.4.Neurological Disorders
13.2.5.Gastrointestinal Disorders
13.2.6.Respiratory Disorders
13.2.7.Others
13.3.  Formulation Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Solid
13.3.2.Liquid
13.3.3.Semi-solid
13.4.  Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Hospital Pharmacies
13.4.2.Retail Pharmacies
13.4.3.Online Pharmacies
13.4.4.Others
14.Japan Asia Pacific Drug Delivery Devices Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
14.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Infusion Pumps
14.1.2.Metered Dose Inhalers
14.1.3.Nebulizers
14.1.4.Syringes
14.1.5.Ocular Inserts
14.1.6.Nasal Sprays
14.1.7.Implantable Drug Delivery Devices
14.1.8.Transdermal Patches
14.1.9.Trans-Mucosal Drug Delivery Devices
14.1.10.Others
14.2.  Application Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Diabetes
14.2.2.Oncology
14.2.3.Autoimmune Disorders
14.2.4.Neurological Disorders
14.2.5.Gastrointestinal Disorders
14.2.6.Respiratory Disorders
14.2.7.Others
14.3.  Formulation Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Solid
14.3.2.Liquid
14.3.3.Semi-solid
14.4.  Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Hospital Pharmacies
14.4.2.Retail Pharmacies
14.4.3.Online Pharmacies
14.4.4.Others
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Becton Dickinson and Company
15.2.2.Hoffmann La Roche Ltd
15.2.3.Smiths medical, Inc.
15.2.4.Braun Melsungen AG
15.2.5.Pfizer Inc.
15.2.6.Merck & Co Inc.
15.2.7.Sanofi S.A.
15.2.8.Abbott Laboratories
15.2.9.Novartis AG
15.2.10.Eli Lilly and company
16. Research Methodology 
17. Appendix and Abbreviations 

Key Market Players

  • Becton Dickinson and Company
  • Hoffmann La Roche Ltd
  • Smiths medical, Inc.
  • Braun Melsungen AG
  • Pfizer Inc.
  • Merck & Co Inc.
  • Sanofi S.A.
  • Abbott Laboratories
  • Novartis AG
  • Eli Lilly and company

Related Industry Reports

Patient Handling Equipment Market

Malaysia Skin Tightening Market

Malaysia Skin Resurfacing Market

Singapore Skin Resurfacing Market